<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-VMQ1P7JF</identifier><date>2013</date><creator>Quartuccio, Natale</creator><relation>documents/doc/V/URN_NBN_SI_doc-VMQ1P7JF_001.pdf</relation><relation>documents/doc/V/URN_NBN_SI_doc-VMQ1P7JF_001.txt</relation><format format_type="issue">2</format><format format_type="volume">47</format><format format_type="type">article</format><format format_type="extent">str. 97-102, I</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">269069312</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-VMQ1P7JF</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">diagnostične metode</subject><subject language_type_id="eng">diagnostika</subject><subject language_type_id="slv">osteosarkom</subject><subject language_type_id="slv">pozitronska emisijska tomografija</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">tomografija</subject><title>The role of Fluorine-18-fluorodeoxyglucose positron emission tomography in staging and restaging of patients with osteosarcoma</title></Record>